Indication
Vimizim is indicated for the treatment of mucopolysaccharidosis, type IVA (Morquio A Syndrome, MPS IVA) in patients of all ages.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- VimizimCanada · 1 MG / ML · Solution · Biomarin International LimitedSame brand
- Vimizim 1MG/ML Concentrado Para Solucion Para PerfusionSpain · 5 mg · concentrado para solución para perfusión · Biomarin International LimitedSame brand
- VimizimCroatiaSame brand
- Vimizim 1 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · BioMarin International Limited